Popular Inc. (BPOP): A Sharp Pullback or a Coiled Spring?

October 31, 2025, 10:25 AM EDT

Whispers on the Street: Decoding the Analyst Chatter

The news surrounding Popular Inc. tells a fascinating story of tempered optimism. On one hand, the company just delivered solid third-quarter results, with both net income and earnings per share ticking up from the previous quarter. That’s the kind of stability investors like to see.

Yet, two major banks recently trimmed their price targets. UBS lowered its target to $127, and Wells Fargo adjusted its to $135. While any reduction can spook the market, it's important to look at the context. Both of these targets are still substantially higher than where the stock is trading now. They aren't waving a red flag; they're just recalibrating their expectations. This happened right after two other analysts, earlier in October, initiated coverage with strong Buy ratings and targets reaching as high as $153. The consensus seems clear: Wall Street believes BPOP has plenty of room to run, even if the path isn't a straight line up.

The Anatomy of a Sell-Off: BPOP's Rollercoaster Ride

The stock chart for the last three months looks like a mountain climb followed by a steep descent. BPOP spent August building a powerful rally, pushing from the low $110s to over $125. By late September, it was knocking on the door of its 52-week high, trading near $128. The momentum felt unstoppable.

Then came October. The trend reversed, and it did so with force. The stock gave back nearly all its gains, tumbling from the high $120s to its current level around $110. This wasn't a gentle drift down; it was a sharp, decisive sell-off, punctuated by days of heavy trading volume. The question now is whether this was a healthy correction or the start of something worse.

The Digital Crystal Ball: A Battle of Indicators

Right now, the data is sending conflicting signals, creating a classic tug-of-war between bearish momentum and bullish potential. Technical indicators like the MACD and DMI confirm what the chart already shows: the recent trend has been negative. There's no arguing with that.

But a different story emerges when you look closer. The stock price is currently bouncing off a key technical support level, a point where buyers have historically stepped in. More importantly, trading volume has surged, which can often signal that the weakest hands have folded and the selling pressure is getting exhausted.

Adding a powerful voice to the bullish side is the AI forecast. The model predicts a rebound over the next three days, with projected gains of 1.9%, 2.2%, and 2.8%. This suggests that, from a purely quantitative perspective, the immediate path of least resistance may be upward. The machine sees a bounce.

The Bottom Line

For investors with a long-term horizon of six months or more, Popular Inc. presents an interesting case. The company appears fundamentally sound, with a reasonable P/E ratio of 11 and steady earnings. The recent, brutal sell-off has pushed its stock down to a level that many analysts and our own AI model view as undervalued.

This looks like a situation for a value-oriented investor who isn't afraid of some choppiness. The data suggests that entry points in the $110.50 to $111.10 range could be strategic. The key is managing the risk. A breakdown below the recent lows would be a warning sign, making a stop-loss near $99.25 a prudent measure.

For those with a shorter timeframe, clearing the $112.50 mark would be the first sign of a real recovery. For longer-term holders, the average analyst price target above $140 suggests a much larger prize could be in store if the company continues to execute and the market sentiment turns.

Disclaimer: This report is for informational purposes only and does not constitute financial, investment, or legal advice. The analysis is based solely on the data provided and is not a guarantee of future performance. All investments carry risk, including the possible loss of principal. You should consult with a qualified professional before making any investment decisions.